. | All-cause death [HR (95% CI, P-value)] . | COAG death [HR (95% CI, P-value)] . | COAG death/uHTx [HR (95% CI, P-value)] . | INF death [HR (95% CI, P-value)] . | INF death/uHTx [HR (95% CI, P-value)] . |
---|---|---|---|---|---|
BSA < 1.867 m2 | 2.086 (1.361–3.197, 0.0007) | 2.665 (1.349–5.265; 0.0048) | 2.621 (1.474–4.660, 0.0010) | 1.572 (0.726–3.405, 0.25) | 1.063 (0.512–2.205, 0.87) |
Age (years) | 1.040 (1.018–1.062, 0.0003) | 1.006 (0.976–1.036, 0.71) | 0.985 (0.962–1.007, 0.18) | 1.077 (1.033–1.123, 0.0005) | 1.027 (0.998–1.058, 0.065) |
INTERMACS level 2a | 1.808 (1.081–3.024, 0.024) | 1.646 (0.709–3.820, 0.25) | 2.338 (1.199–4.560, 0.013) | 1.575 (0.640–3.879, 0.32) | 1.387 (0.572–3.367, 0.47) |
Albumin (g/dl) | 0.683 (0.458–1.020, 0.062) | 0.802 (0.415–1.548, 0.51) | 1.211 (0.705–2.081, 0.49) | 0.509 (0.255–1.018, 0.056) | 0.748 (0.423–1.324, 0.32) |
Body mass index (kg/m2) | 0.967 (0.921–1.014, 0.17) | 0.934 (0.860–1.014, 0.10) | 0.933 (0.871–0.999, 0.045) | 0.978 (0.900–1.062, 0.59) | 0.999 (0.936–1.067, 0.98) |
Female gender | 1.343 (0.697–2.587, 0.38) | 1.445 (0.510–4.099, 0.49) | 1.569 (0.668–3.687, 0.30) | 0.368 (0.050–2.697, 0.33) | 0.273 (0.038–1.986, 0.20) |
Serum creatinine (mg/dl) | 1.102 (0.804–1.512, 0.55) | 0.611 (0.315–1.185, 0.15) | 0.835 (0.508–1.373, 0.48) | 1.298 (0.786–2.144, 0.31) | 1.167 (0.742–1.835, 0.51) |
Indication for LVAD | |||||
Bridge to transplant | 1 | 1 | 1 | 1 | 1 |
Bridge to candidacy | 1.357 (0.825–2.231, 0.23) | 2.281 (0.997–5.219, 0.051) | 1.460 (0.787– 2.709, 0.23) | 0.377 (0.134–1.060, 0.064) | 0.531 (0.257–1.097, 0.087) |
Bridge to recovery | 1.894 (0.823–4.360, 0.13) | 1.736 (0.367–8.202, 0.49) | 0.881 (0.203–3.827, 0.87) | 2.170 (0.705–6.683, 0.18) | 1.402 (0.481–4.086, 0.54) |
Destination therapy | 2.158 (1.258–3.702, 0.0052) | 1.656 (0.574–4.779, 0.35) | 0.799 (0.315–2.028, 0.64) | 1.907 (0.853–4.265, 0.12) | 1.156 (0.560–2.388, 0.69) |
Surgical approach | |||||
Primary sternotomy | 1 | 1 | 1 | 1 | 1 |
Re-sternotomy | 1.355 (0.730–2.514, 0.34) | 0.783 (0.237–2.585, 0.69) | 0.749 (0.267– 2.097, 0.58) | 1.469 (0.499–4.326, 0.48) | 1.387 (0.578–3.330, 0.46) |
Left lateral thoracotomy | 1.713 (1.053–2.788, 0.030) | 0.912 (0.351– 2.370, 0.85) | 0.887 (0.396–1.984, 0.77) | 2.548 (1.184–5.484, 0.017) | 1.744 (0.875–3.474, 0.11) |
. | All-cause death [HR (95% CI, P-value)] . | COAG death [HR (95% CI, P-value)] . | COAG death/uHTx [HR (95% CI, P-value)] . | INF death [HR (95% CI, P-value)] . | INF death/uHTx [HR (95% CI, P-value)] . |
---|---|---|---|---|---|
BSA < 1.867 m2 | 2.086 (1.361–3.197, 0.0007) | 2.665 (1.349–5.265; 0.0048) | 2.621 (1.474–4.660, 0.0010) | 1.572 (0.726–3.405, 0.25) | 1.063 (0.512–2.205, 0.87) |
Age (years) | 1.040 (1.018–1.062, 0.0003) | 1.006 (0.976–1.036, 0.71) | 0.985 (0.962–1.007, 0.18) | 1.077 (1.033–1.123, 0.0005) | 1.027 (0.998–1.058, 0.065) |
INTERMACS level 2a | 1.808 (1.081–3.024, 0.024) | 1.646 (0.709–3.820, 0.25) | 2.338 (1.199–4.560, 0.013) | 1.575 (0.640–3.879, 0.32) | 1.387 (0.572–3.367, 0.47) |
Albumin (g/dl) | 0.683 (0.458–1.020, 0.062) | 0.802 (0.415–1.548, 0.51) | 1.211 (0.705–2.081, 0.49) | 0.509 (0.255–1.018, 0.056) | 0.748 (0.423–1.324, 0.32) |
Body mass index (kg/m2) | 0.967 (0.921–1.014, 0.17) | 0.934 (0.860–1.014, 0.10) | 0.933 (0.871–0.999, 0.045) | 0.978 (0.900–1.062, 0.59) | 0.999 (0.936–1.067, 0.98) |
Female gender | 1.343 (0.697–2.587, 0.38) | 1.445 (0.510–4.099, 0.49) | 1.569 (0.668–3.687, 0.30) | 0.368 (0.050–2.697, 0.33) | 0.273 (0.038–1.986, 0.20) |
Serum creatinine (mg/dl) | 1.102 (0.804–1.512, 0.55) | 0.611 (0.315–1.185, 0.15) | 0.835 (0.508–1.373, 0.48) | 1.298 (0.786–2.144, 0.31) | 1.167 (0.742–1.835, 0.51) |
Indication for LVAD | |||||
Bridge to transplant | 1 | 1 | 1 | 1 | 1 |
Bridge to candidacy | 1.357 (0.825–2.231, 0.23) | 2.281 (0.997–5.219, 0.051) | 1.460 (0.787– 2.709, 0.23) | 0.377 (0.134–1.060, 0.064) | 0.531 (0.257–1.097, 0.087) |
Bridge to recovery | 1.894 (0.823–4.360, 0.13) | 1.736 (0.367–8.202, 0.49) | 0.881 (0.203–3.827, 0.87) | 2.170 (0.705–6.683, 0.18) | 1.402 (0.481–4.086, 0.54) |
Destination therapy | 2.158 (1.258–3.702, 0.0052) | 1.656 (0.574–4.779, 0.35) | 0.799 (0.315–2.028, 0.64) | 1.907 (0.853–4.265, 0.12) | 1.156 (0.560–2.388, 0.69) |
Surgical approach | |||||
Primary sternotomy | 1 | 1 | 1 | 1 | 1 |
Re-sternotomy | 1.355 (0.730–2.514, 0.34) | 0.783 (0.237–2.585, 0.69) | 0.749 (0.267– 2.097, 0.58) | 1.469 (0.499–4.326, 0.48) | 1.387 (0.578–3.330, 0.46) |
Left lateral thoracotomy | 1.713 (1.053–2.788, 0.030) | 0.912 (0.351– 2.370, 0.85) | 0.887 (0.396–1.984, 0.77) | 2.548 (1.184–5.484, 0.017) | 1.744 (0.875–3.474, 0.11) |
CI: confidence interval; COAG death: death due to stroke or systemic bleeding; COAG death/uHTx: death due to stroke or systemic bleeding, or urgent heart transplantation due to difficulties of coagulation management (i.e. embolic events or bleeding); HR: hazard ratio; INF death: death due to sepsis; INF death/uHTx: death due to sepsis, or urgent heart transplantation due to device infection.
aINTERMACS level 2 vs levels 3 and 4. P-values less than 0.10 are shown in bold.
. | All-cause death [HR (95% CI, P-value)] . | COAG death [HR (95% CI, P-value)] . | COAG death/uHTx [HR (95% CI, P-value)] . | INF death [HR (95% CI, P-value)] . | INF death/uHTx [HR (95% CI, P-value)] . |
---|---|---|---|---|---|
BSA < 1.867 m2 | 2.086 (1.361–3.197, 0.0007) | 2.665 (1.349–5.265; 0.0048) | 2.621 (1.474–4.660, 0.0010) | 1.572 (0.726–3.405, 0.25) | 1.063 (0.512–2.205, 0.87) |
Age (years) | 1.040 (1.018–1.062, 0.0003) | 1.006 (0.976–1.036, 0.71) | 0.985 (0.962–1.007, 0.18) | 1.077 (1.033–1.123, 0.0005) | 1.027 (0.998–1.058, 0.065) |
INTERMACS level 2a | 1.808 (1.081–3.024, 0.024) | 1.646 (0.709–3.820, 0.25) | 2.338 (1.199–4.560, 0.013) | 1.575 (0.640–3.879, 0.32) | 1.387 (0.572–3.367, 0.47) |
Albumin (g/dl) | 0.683 (0.458–1.020, 0.062) | 0.802 (0.415–1.548, 0.51) | 1.211 (0.705–2.081, 0.49) | 0.509 (0.255–1.018, 0.056) | 0.748 (0.423–1.324, 0.32) |
Body mass index (kg/m2) | 0.967 (0.921–1.014, 0.17) | 0.934 (0.860–1.014, 0.10) | 0.933 (0.871–0.999, 0.045) | 0.978 (0.900–1.062, 0.59) | 0.999 (0.936–1.067, 0.98) |
Female gender | 1.343 (0.697–2.587, 0.38) | 1.445 (0.510–4.099, 0.49) | 1.569 (0.668–3.687, 0.30) | 0.368 (0.050–2.697, 0.33) | 0.273 (0.038–1.986, 0.20) |
Serum creatinine (mg/dl) | 1.102 (0.804–1.512, 0.55) | 0.611 (0.315–1.185, 0.15) | 0.835 (0.508–1.373, 0.48) | 1.298 (0.786–2.144, 0.31) | 1.167 (0.742–1.835, 0.51) |
Indication for LVAD | |||||
Bridge to transplant | 1 | 1 | 1 | 1 | 1 |
Bridge to candidacy | 1.357 (0.825–2.231, 0.23) | 2.281 (0.997–5.219, 0.051) | 1.460 (0.787– 2.709, 0.23) | 0.377 (0.134–1.060, 0.064) | 0.531 (0.257–1.097, 0.087) |
Bridge to recovery | 1.894 (0.823–4.360, 0.13) | 1.736 (0.367–8.202, 0.49) | 0.881 (0.203–3.827, 0.87) | 2.170 (0.705–6.683, 0.18) | 1.402 (0.481–4.086, 0.54) |
Destination therapy | 2.158 (1.258–3.702, 0.0052) | 1.656 (0.574–4.779, 0.35) | 0.799 (0.315–2.028, 0.64) | 1.907 (0.853–4.265, 0.12) | 1.156 (0.560–2.388, 0.69) |
Surgical approach | |||||
Primary sternotomy | 1 | 1 | 1 | 1 | 1 |
Re-sternotomy | 1.355 (0.730–2.514, 0.34) | 0.783 (0.237–2.585, 0.69) | 0.749 (0.267– 2.097, 0.58) | 1.469 (0.499–4.326, 0.48) | 1.387 (0.578–3.330, 0.46) |
Left lateral thoracotomy | 1.713 (1.053–2.788, 0.030) | 0.912 (0.351– 2.370, 0.85) | 0.887 (0.396–1.984, 0.77) | 2.548 (1.184–5.484, 0.017) | 1.744 (0.875–3.474, 0.11) |
. | All-cause death [HR (95% CI, P-value)] . | COAG death [HR (95% CI, P-value)] . | COAG death/uHTx [HR (95% CI, P-value)] . | INF death [HR (95% CI, P-value)] . | INF death/uHTx [HR (95% CI, P-value)] . |
---|---|---|---|---|---|
BSA < 1.867 m2 | 2.086 (1.361–3.197, 0.0007) | 2.665 (1.349–5.265; 0.0048) | 2.621 (1.474–4.660, 0.0010) | 1.572 (0.726–3.405, 0.25) | 1.063 (0.512–2.205, 0.87) |
Age (years) | 1.040 (1.018–1.062, 0.0003) | 1.006 (0.976–1.036, 0.71) | 0.985 (0.962–1.007, 0.18) | 1.077 (1.033–1.123, 0.0005) | 1.027 (0.998–1.058, 0.065) |
INTERMACS level 2a | 1.808 (1.081–3.024, 0.024) | 1.646 (0.709–3.820, 0.25) | 2.338 (1.199–4.560, 0.013) | 1.575 (0.640–3.879, 0.32) | 1.387 (0.572–3.367, 0.47) |
Albumin (g/dl) | 0.683 (0.458–1.020, 0.062) | 0.802 (0.415–1.548, 0.51) | 1.211 (0.705–2.081, 0.49) | 0.509 (0.255–1.018, 0.056) | 0.748 (0.423–1.324, 0.32) |
Body mass index (kg/m2) | 0.967 (0.921–1.014, 0.17) | 0.934 (0.860–1.014, 0.10) | 0.933 (0.871–0.999, 0.045) | 0.978 (0.900–1.062, 0.59) | 0.999 (0.936–1.067, 0.98) |
Female gender | 1.343 (0.697–2.587, 0.38) | 1.445 (0.510–4.099, 0.49) | 1.569 (0.668–3.687, 0.30) | 0.368 (0.050–2.697, 0.33) | 0.273 (0.038–1.986, 0.20) |
Serum creatinine (mg/dl) | 1.102 (0.804–1.512, 0.55) | 0.611 (0.315–1.185, 0.15) | 0.835 (0.508–1.373, 0.48) | 1.298 (0.786–2.144, 0.31) | 1.167 (0.742–1.835, 0.51) |
Indication for LVAD | |||||
Bridge to transplant | 1 | 1 | 1 | 1 | 1 |
Bridge to candidacy | 1.357 (0.825–2.231, 0.23) | 2.281 (0.997–5.219, 0.051) | 1.460 (0.787– 2.709, 0.23) | 0.377 (0.134–1.060, 0.064) | 0.531 (0.257–1.097, 0.087) |
Bridge to recovery | 1.894 (0.823–4.360, 0.13) | 1.736 (0.367–8.202, 0.49) | 0.881 (0.203–3.827, 0.87) | 2.170 (0.705–6.683, 0.18) | 1.402 (0.481–4.086, 0.54) |
Destination therapy | 2.158 (1.258–3.702, 0.0052) | 1.656 (0.574–4.779, 0.35) | 0.799 (0.315–2.028, 0.64) | 1.907 (0.853–4.265, 0.12) | 1.156 (0.560–2.388, 0.69) |
Surgical approach | |||||
Primary sternotomy | 1 | 1 | 1 | 1 | 1 |
Re-sternotomy | 1.355 (0.730–2.514, 0.34) | 0.783 (0.237–2.585, 0.69) | 0.749 (0.267– 2.097, 0.58) | 1.469 (0.499–4.326, 0.48) | 1.387 (0.578–3.330, 0.46) |
Left lateral thoracotomy | 1.713 (1.053–2.788, 0.030) | 0.912 (0.351– 2.370, 0.85) | 0.887 (0.396–1.984, 0.77) | 2.548 (1.184–5.484, 0.017) | 1.744 (0.875–3.474, 0.11) |
CI: confidence interval; COAG death: death due to stroke or systemic bleeding; COAG death/uHTx: death due to stroke or systemic bleeding, or urgent heart transplantation due to difficulties of coagulation management (i.e. embolic events or bleeding); HR: hazard ratio; INF death: death due to sepsis; INF death/uHTx: death due to sepsis, or urgent heart transplantation due to device infection.
aINTERMACS level 2 vs levels 3 and 4. P-values less than 0.10 are shown in bold.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.